Roivant Sciences ROIV
NASDAQ ROIV
$36.81 +1.89 (+5.41%)
As of: Oct 21, 2026 · 10:01 AM EDT

Roivant Sciences (ROIV) Notes Payables (2022)

Updated

Roivant Sciences (ROIV) recorded Notes Payables of $33.3 million in fiscal Q1 2023 (quarter ended Jun 30, 2022).

Analysis

Roivant Sciences (ROIV) Notes Payables (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.25 Bn 1,104.84 Bn 19.71 Bn
2 Johnson & Johnson 615.56 Bn 534.09 Bn 17.26 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn
5 Novartis Ag 298.15 Bn 262.14 Bn 11.24 Bn
6 Astrazeneca 262.32 Bn 236.01 Bn 12.86 Bn
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn
8 Gilead Sciences 191.30 Bn 165.50 Bn 6.22 Bn
9 Pfizer 170.97 Bn 117.62 Bn 10.94 Bn
10 Roivant Sciences 26.48 Bn 9.43 Bn 1.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 33.30 Mn
API Access

Roivant Sciences Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ROIV&period=max&api_key=YOUR_API_KEY